El orden de la biopsia no altera el resultado
Diagnostic Performance of DIF Microscopy Studies by Biopsy Sites in Autoimmune Subepidermal Blistering Dermatoses
TAKE-HOME MESSAGE
Forty-three patients with autoimmune blistering diseases were included in this study, of which 40 had bullous pemphigoid, 2 had epidermolysis bullosa aquisita, and 1 had linear IgA bullous dermatosis. Biopsies from both normal-appearing skin within 2 cm of a blister and from erythematous nonblistered skin were obtained from each patient and submitted for direct immunofluorescence (DIF) testing. There was no significant difference in DIF positivity between adjacent normal-appearing skin (83.7%) and erythematous nonblistered skin (74.4%). There was also no difference between normal versus erythematous skin for rates of linear deposition of IgG (72.1% vs 62.8%), IgA (14.3% for both), C3 (74.4% vs 69.8%), or IgE (10% vs 12.5%).
- A biopsy from either site for DIF should aid in the diagnosis of autoimmune blistering disease.
Abstract
The British Journal of Dermatology
Diagnostic Performance of Direct Immunofluorescence Microscopy Studies by Biopsy Sites in Autoimmune Subepidermal Blistering Dermatoses: A Prospective Study
Br J Dermatol 2020 Jun 07;[EPub Ahead of Print], S Haefliger, S Sitaru, S Cazzaniga, A Rammlmair, L Feldmeyer, MP Horn, L BorradoriSkin Care Physicians of Costa Rica
Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574
Please excuse the shortness of this message, as it has been sent from
a mobile device.
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home